Trends Mergers & Acquisitions

and clients

Trends Mergers & Acquisitions has been involved in over 200 reverse merger transactions, providing M & A services, along with capital raising capabilities to companies in the United States and internationally. With direct links to Europe, Asia, and North and South America Trends serves as a vehicle to access capital markets around the globe.

Transactions and Clients

PNPL - pineapple express

Pineapple Express (PNPL) is a publicly traded company that provides capital to our canna-business clientele, leases real properties to those canna-businesses, and provides consulting and technology to develop, enhance, and/or expand existing and newly formed infrastructures. We intend to create a nationally branded chain of company owned cannabis retail stores under the “Pineapple Express” name as soon as federal laws allow

CSAX - Canna Securities

CannaSecurity (CSAX) specializes in engineering custom security systems specifically to ensure full compliance with all federal, state, and local laws. CSAX provides effective security solutions to cannabis businesses, including alarms, door access systems, video surveillance, security system design, and state licensing consulting. With over 400 permitted facilities utilizing CSA security systems installed across multiple states all acquiring 100% licensing approval rating, Canna Security America is recognized as the gold-standard in security services and technology for the industry.

MICB - Microlin Bio

Microlin Bio (MICB) is an emerging therapeutics company focusing on microRNA and its role in oncology.  MicroRNAs are recently discovered naturally-occurring RNA molecules (composed of 19 to 25 nucleotides) that do not encode proteins but instead regulate gene expression and various biological pathways. The improper balance of microRNAs is believed to be linked to many diseases, including cancer.

EMBT - ember therapeutics

Ember Therapeutics (EMBT) is a biopharmaceutical company whose primary focus is on utilizing Bone Morphogenetic Protein-7 (BMP-7) and related family of BMPs, mutants, variants, novel formulations, and delivery technologies to develop regenerative medicines for disease modification of osteoarthritis, reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases such as chronic kidney disease and Alport Syndrome.